Patents by Inventor Evan D. Rosen

Evan D. Rosen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Lipocalin 2 in the Regulation of Insulin Sensitivity
    Publication number: 20100247551
    Abstract: Methods of identifying compounds that modulate lipocalin 2 activity or expression are described, as are methods of reducing insulin resistance or increasing insulin sensitivity by administering compounds that modulate lipocalin 2 expression. Methods of diagnosing insulin resistance or related conditions, by measuring lipocalin 2 activity, are also described.
    Type: Application
    Filed: August 29, 2007
    Publication date: September 30, 2010
    Inventor: Evan D. Rosen